Table 1.
Expression of HSP gp96 with clinicopathologic parameters in gallbladder adenocarcinoma and adenoma
| Group | NO. of cases | HSP gp96-positive (%) | P |
|---|---|---|---|
| Gallbladder adenocarcinoma | |||
| Overall | 107 | 97 (90.7) | |
| Age (years) | |||
| < 61 | 54 | 46 (85.19) | 0.0930 |
| ≥ 61 | 53 | 51 (96.23) | |
| Sex | |||
| Male | 38 | 33 (86.84) | 0.3218 |
| Female | 69 | 64 (92.75) | |
| Differentiated | |||
| Well | 32 | 27 (84.38) | 0.1953 |
| Moderately | 40 | 36 (90.00) | |
| Poorly | 35 | 34 (97.14) | |
| Lymph node metastasis | |||
| Positive | 58 | 57 (98.28) | 0.0051 |
| Negative | 49 | 40 (81.63) | |
| Tumor depth | |||
| T1 | 6 | 4 (66.67) | 0.0096 |
| T2 | 35 | 29 (82.86) | |
| T3 | 35 | 33 (94.29) | |
| T4 | 31 | 31 (100) | |
| Gallstone | |||
| Yes | 48 | 44 (91.67) | 1.000 |
| No | 59 | 53 (89.83) | |
| Gallbladder adenoma | |||
| Overall | 70 | 50 (71.43) | |
| Chronic cholecystitis | |||
| Overall | 67 | 18 (26.87) |